Javascript must be enabled to continue!
A screen for nonconditional dauer-constitutive mutations in Caenorhabditis elegans.
View through CrossRef
Abstract
In Caenorhabditis elegans, formation of the developmentally arrested dauer larva is induced by high levels of a constitutively secreted pheromone. Synergy between two groups of incompletely penetrant dauer-constitutive (Daf-c) mutations has recently led to a proposal that these two groups of genes are partially redundant and function in two parallel pathways that regulate dauer formation. A possible weakness in this reasoning is that the mutations used to identify the synergy were specifically obtained as incompletely penetrant mutations. Here we use screens to identify new Daf-c alleles without any requirement for partial penetrance. Nevertheless, 22 of the 25 new mutations are incompletely penetrant mutations in 6 previously identified genes. Among these are mutations in daf-8 and daf-19, genes for which only one mutation had been previously identified. Also included in this group are three daf-1 alleles that do not exhibit the maternal rescue characteristic of other daf-1 alleles. Two of the 25 new mutations are fully penetrant and are alleles of daf-2, the one gene in which a fully penetrant mutation had been found earlier. Finally, one of the 25 new mutations is semidominant, temperature-sensitive, and identifies a new gene, daf-28. The results demonstrate that an incompletely penetrant Daf-c phenotype is characteristic of mutations in most Daf-c genes other than daf-2. This finding strengthens the hypothesis that a branched genetic pathway controls dauer formation.
Title: A screen for nonconditional dauer-constitutive mutations in Caenorhabditis elegans.
Description:
Abstract
In Caenorhabditis elegans, formation of the developmentally arrested dauer larva is induced by high levels of a constitutively secreted pheromone.
Synergy between two groups of incompletely penetrant dauer-constitutive (Daf-c) mutations has recently led to a proposal that these two groups of genes are partially redundant and function in two parallel pathways that regulate dauer formation.
A possible weakness in this reasoning is that the mutations used to identify the synergy were specifically obtained as incompletely penetrant mutations.
Here we use screens to identify new Daf-c alleles without any requirement for partial penetrance.
Nevertheless, 22 of the 25 new mutations are incompletely penetrant mutations in 6 previously identified genes.
Among these are mutations in daf-8 and daf-19, genes for which only one mutation had been previously identified.
Also included in this group are three daf-1 alleles that do not exhibit the maternal rescue characteristic of other daf-1 alleles.
Two of the 25 new mutations are fully penetrant and are alleles of daf-2, the one gene in which a fully penetrant mutation had been found earlier.
Finally, one of the 25 new mutations is semidominant, temperature-sensitive, and identifies a new gene, daf-28.
The results demonstrate that an incompletely penetrant Daf-c phenotype is characteristic of mutations in most Daf-c genes other than daf-2.
This finding strengthens the hypothesis that a branched genetic pathway controls dauer formation.
Related Results
ВОЗМОЖНАЯ РОЛЬ РЕЦЕПТОРОВ ДОФАМИНА DOP-1, DOP-2 И DOP-3 В МОДУЛЯЦИИ ЧУВСТВИТЕЛЬНОСТИ ПОЧВЕННОЙ НЕМАТОДЫ Caenorhabditis elegans К ТОКСИЧЕСКОМУ ДЕЙСТВИЮ ИОНОВ СВИНЦА
ВОЗМОЖНАЯ РОЛЬ РЕЦЕПТОРОВ ДОФАМИНА DOP-1, DOP-2 И DOP-3 В МОДУЛЯЦИИ ЧУВСТВИТЕЛЬНОСТИ ПОЧВЕННОЙ НЕМАТОДЫ Caenorhabditis elegans К ТОКСИЧЕСКОМУ ДЕЙСТВИЮ ИОНОВ СВИНЦА
Проведено изучение возможной роли рецепторов дофамина DOP-1, DOP-2 и DOP-3 в модуляции чувствительности почвенной нематоды Caenorhabditis elegans к токсическому действию нитрата св...
Neuronal IL-17 controls
C. elegans
developmental diapause through CEP-1/p53
Neuronal IL-17 controls
C. elegans
developmental diapause through CEP-1/p53
Abstract
During metazoan development, how cell division and metabolic programs are coordinated with nutrient availability remains unclear. Here, ...
Robustness and variability in
Caenorhabditis elegans
dauer gene expression
Robustness and variability in
Caenorhabditis elegans
dauer gene expression
ABSTRACT
Both plasticity and robustness are pervasive features of developmental programs. The dauer in
Caenorhabditis elegans
...
Dauer quiescence as well as continuity of the life cycle after dauer-exit in Caenorhabditis elegans are dependent on the endoribonuclease activity of XRN-2
Dauer quiescence as well as continuity of the life cycle after dauer-exit in Caenorhabditis elegans are dependent on the endoribonuclease activity of XRN-2
AbstractCaenorhabditis elegans embarks on a quiescent dauer state upon exposure to unfavourable conditions and can sustain for a very long period without food, but it returns to co...
Tolerance to a Diet of Toxic Microcystis aeruginosa in Caenorhabditis elegans
Tolerance to a Diet of Toxic Microcystis aeruginosa in Caenorhabditis elegans
Reported incidences of cyanobacterial harmful algal blooms (CHABs) are increasing across the world due to climate change and nutrient loading, dominating freshwater ecosystems and ...
Evaluation of Known Human PDE Inhibitors Against Nematode PDE4s
Evaluation of Known Human PDE Inhibitors Against Nematode PDE4s
Abstract
Parasitic nematodes are responsible for more than one and a half billion infections world-wide. The drugs developed against these infect...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
Abstract
Background
Recent reports have highlighted an adverse impact of TP53 mutations on the prognosis of patients with myeloid malignancies. TP53 m...

